PR Newswire

SIR-Spheres® Y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC)

Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer (mCRC) endorse radioembolisation, specifically with Yttrium-90 resin ...
News Medical

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Moreover, those patients treated with SIR-Spheres Y-90 resin microspheres who reported treatment-related side effects experienced a median of only 5 such events over the course of the SARAH study, ...
Pharm Exec

FDA Approves Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma

Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...
Finanznachrichten

Sirtex Medical Inc.: Sirtex Medical's SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Expanded indication makes SIR-Spheres ® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, ...